Early research (Phase 1)Study completedNCT00121680
What this trial is testing
A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic Melanoma
Who this might be right for
Metastatic Melanoma
Eisai Inc. 115